B
BreezeBio
BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.
About
BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an internal therapeutic pipeline with an initial focus on autoimmune diseases and oncology, with its lead candidate, BRZ-101, designed to restore immune tolerance in Type 1 diabetes. BreezeBio also engages in partnered programs to leverage its delivery technology.
Tags
Total Employees
63
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
48Traction
58Team
60Visibility
10Profile
80Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BreezeBio do?
BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an intern…
How much funding has BreezeBio raised?
BreezeBio has raised a total of $94M in funding. The most recent round on record is Series B.
Where is BreezeBio headquartered?
BreezeBio is headquartered in Alameda, California, US.
When was BreezeBio founded?
BreezeBio was founded in 2016.
What industry does BreezeBio operate in?
BreezeBio operates in Biotechnology, Genetic Medicine, Therapeutics, Drug Discovery.
How many employees does BreezeBio have?
BreezeBio has approximately 63 people on record.